Clinical trial

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

NCT03424733

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-09-25

PhasePHASE4

Study timeline

Study start (actual)2017-09-25Date precision: day

Registry last updated2019-08-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

PlegridyDRUG · verified · RxNorm: Plegridy

PrednisoneDRUG · verified · RxNorm: prednisone

Tylenol PillDRUG

Sponsors & collaborators

Holy Name Medical Center, Inc.lead sponsor

Biogencollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03424733 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.